Abstract
Brn-3b transcription factor enhances proliferation of neuroblastoma (NB) and breast cancer cell lines in vitro and increases the rate and size of in vivo tumour growth, whereas reducing Brn-3b slows growth, both in vitro and in vivo. Brn-3b is elevated in >65% of breast cancer biopsies, and here we demonstrate that Brn-3b is also elevated in NB tumours. We show a significant correlation between Brn-3b and cyclin D1 (CD1) in breast cancers and NB tumours and cell lines. Brn-3b directly transactivates the CD1 promoter in co-transfection experiments, whereas electrophoretic mobility shift assay and chromatin immunoprecipitation assays demonstrate that Brn-3b protein binds to an octamer sequence located in the proximal CD1 promoter. Site-directed mutagenesis of this sequence resulted in loss of transactivation of the CD1 promoter by Brn-3b. Thus, Brn-3b may act to alter growth properties of breast cancer and NB cells by enhancing CD1 expression in these cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
Change history
09 February 2023
A Correction to this paper has been published: https://doi.org/10.1038/s41388-023-02614-9
Abbreviations
- CD1:
-
cyclin D1
- ChIP:
-
chromatin immunoprecipitation
- EMSA:
-
electrophoretic mobility shift assay
- LTR:
-
long terminal repeat
- NB:
-
neuroblastoma
- POU:
-
Pit-Oct-Unc
- RA:
-
retinoic acid
References
Arnold A, Motokura T, Bloom T, Kronenberg H, Ruderman J, Juppner H et al. (1991). The putative oncogene PRAD1 encodes a novel cyclin. Cold Spring Harb Symp Quant Biol 56: 93–97.
Barnes DM, Gillett CE . (1998). Cyclin D1 in breast cancer. Breast Cancer Res Treat 52: 1–15.
Bienvenu F, Gascan H, Coqueret O . (2001). Cyclin D1 represses STAT3 activation through a Cdk4-independent mechanism. J Biol Chem 276: 16840–16847.
Brodeur GM . (2003). Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203–216.
Budhram-Mahadeo V, Lillycrop KA, Latchman DS . (1995). The levels of the antagonistic POU family transcription factors Brn-3a and Brn-3b in neuronal cells are regulated in opposite directions by serum growth factors. Neurosci Lett 185: 48–51.
Budhram-Mahadeo V, Morris PJ, Ward T, Weber B, Sassone-Corsi P, Latchman DS . (2001). The closely related POU family transcription factors Brn-3a and Brn-3b are expressed in distinct cell types in the testis. Int J Biochem Cell Biol 33: 1027–1039.
Budhram-Mahadeo V, Ndisang D, Ward T, Weber BL, Latchman DS . (1999). The Brn-3b POU family transcription factor represses expression of the BRCA-1 anti-oncogene in breast cancer cells. Oncogene 18: 6684–6691.
Budhram-Mahadeo V, Theil T, Morris PJ, Lillycrop KA, Moroy T, Latchman DS . (1994). The DNA target site for the Brn-3 POU family transcription factors can confer responsiveness to cyclic AMP and removal of serum in neuronal cells. Nucleuc Acid Res 22: 3092–3098.
Budhram-Mahadeo VS, Latchman DS . (2006). Targeting Brn-3b in breast cancer therapy. Expert Opin Ther Targets 10: 15–25.
Dennis JH, Budhram-Mahadeo V, Latchman DS . (2001). The Brn-3b POU family transcription factor regulates the cellular growth, proliferation, and anchorage dependence of MCF7 human breast cancer cells. Oncogene 20: 4961–4971.
Erkman L, McEvilly RJ, Luo L, Ryan AK, Hooshmand F, O'Connell SM et al. (1996). Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. Nature 381: 603–606.
Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C . (1995). Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 9: 2364–2372.
Gan L, Xiang M, Zhou L, Wagner DS, Klein WH, Nathans J . (1996). POU domain factor Brn-3b is required for the development of a large set of retinal ganglion cells. Proc Natl Acad Sci USA 93: 3920–3925.
Guo Y, Yang K, Harwalkar J, Nye JM, Mason DR, Garrett MD et al. (2005). Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis. Oncogene 24: 2599–2612.
Irshad S, Pedley RB, Anderson J, Latchman DS, Budhram-Mahadeo V . (2004). The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. J Biol Chem 279: 21617–21627.
Israels ED, Israels LG . (2000). The cell cycle. Oncologist 5: 510–513.
Knudsen KE, Cavenee WK, Arden KC . (1999). D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability. Cancer Res 59: 2297–2301.
Latchman DS . (1998a). Regulation of neuronal differentiation and apoptosis by Brn-3 POU family transcription factors: potential use in gene therapy. Gene Ther Mol Biol 2: 95–101.
Latchman DS . (1998b). The Brn-3a transcription factor. Int J Biochem Cell Biol 30: 1153–1157.
Lee SA, Ndisang D, Patel C, Dennis JH, Faulkes DJ, D'Arrigo C et al. (2005). Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of the HSP-27 promoter. Cancer Res 65: 3072–3080.
Lillycrop KA, Budhram-Mahadeo V, Lakin ND, Terrenghi G, Wood JN, Polak JM et al. (1992). A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells. Nucleic Acids Res 20: 5093–5096.
Molenaar JJ, van Sluis P, Boon K, Versteeg R, Caron HN . (2003). Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma. Genes Chromosomes Cancer 36: 242–249.
Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM et al. (1991). A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350: 512–515.
Mu X, Zhao S, Pershad R, Hsieh TF, Scarpa A, Wang SW et al. (2001). Gene expression in the developing mouse retina by EST sequencing and microarray analysis. Nucleic Acids Res 29: 4983–4993.
Redeuilh G, Attia A, Mester J, Sabbah M . (2002). Transcriptional activation by the oestrogen receptor alpha is modulated through inhibition of cyclin-dependent kinases. Oncogene 21: 5773–5782.
Sabbah M, Courilleau D, Mester J, Redeuilh G . (1999). Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc Natl Acad Sci USA 96: 11217–11222.
Samady L, Dennis J, Budhram-Mahadeo V, Latchman DS . (2004). Activation of CDK4 gene expression in human breast cancer cells by the Brn-3b POU family transcription factor. Cancer Biol Ther 3: 317–323.
Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H et al. (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621–630.
Smith MD, Latchman DS . (1996). The functionally antagonistic POU family transcription factors Brn-3a and Brn-3b show opposite changes in expression during the growth arrest and differentiation of human neuroblastoma cells. Int J Cancer 67: 653–660.
Turner EE, Jenne KJ, Rosenfeld MG . (1994). Brn-3.2: a Brn-3-related transcription factor with distinctive central nervous system expression and regulation by retinoic acid. Neuron 12: 205–218.
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. (2002). Accurate normalization of real-time quantitative RT–PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 (7): RESEARCH0034; 1–12.
Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV . (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669–671.
Weinberg RA . (1995). The retinoblastoma protein and cell cycle control. Cell 81: 323–330.
Xiang M . (1998). Requirement for Brn-3b in early differentiation of postmitotic retinal ganglion cell precursors. Dev Biol 197: 155–169.
Xiang M, Zhou L, Nathans J . (1996). Similarities and differences among inner retinal neurons revealed by the expression of reporter transgenes controlled by Brn-3a, Brn-3b, and Brn-3c promotor sequences. Vis Neurosci 13: 955–962.
Xiang M, Zhou L, Peng YW, Eddy RL, Shows TB, Nathans J . (1993). Brn-3b: a POU domain gene expressed in a subset of retinal ganglion cells. Neuron 11: 689–701.
Zwijsen RM, Klompmaker R, Wientjens EB, Kristel PM, van der BB, Michalides RJ . (1996). Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol Cell Biol 16: 2554–2560.
Zwijsen RM, Wientjens E, Klompmaker R, van der SJ, Bernards R, Michalides RJ . (1997). CDK-independent activation of estrogen receptor by cyclin D1. Cell 88: 405–415.
Acknowledgements
We thank Dr Gerard Redeuilh (Paris, France) for cyclin D1 reporter constructs; Dr J Anderson and Dr P Brock (Great Ormond Street Hospital (GOSH), London) for support and discussions; Italian Neuroblastoma Society; Pathology Department (GOSH, London) and UKCCSG, UK for NB RNA or biopsies; Dr D' Arrigo (Guy's Hospital, London) for breast cancer biopsies and Candis Tissue Bank (Liverpool, UK) for RNA from breast cancer. This work was supported by Child Health Research Action Trust (CHRAT); Breast Cancer Campaign (BCC) UK; Association for International Cancer Research (AICR), UK.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Budhram-Mahadeo, V., Irshad, S., Bowen, S. et al. Proliferation-associated Brn-3b transcription factor can activate cyclin D1 expression in neuroblastoma and breast cancer cells. Oncogene 27, 145–154 (2008). https://doi.org/10.1038/sj.onc.1210621
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.onc.1210621
Keywords
This article is cited by
-
Vascular dysfunction caused by loss of Brn-3b/POU4F2 transcription factor in aortic vascular smooth muscle cells is linked to deregulation of calcium signalling pathways
Cell Death & Disease (2023)
-
Linking metabolic dysfunction with cardiovascular diseases: Brn-3b/POU4F2 transcription factor in cardiometabolic tissues in health and disease
Cell Death & Disease (2021)
-
The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart
Cell Death & Disease (2019)
-
Essential but partially redundant roles for POU4F1/Brn-3a and POU4F2/Brn-3b transcription factors in the developing heart
Cell Death & Disease (2017)
-
Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway
Breast Cancer Research (2011)


